Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Nov-23 6:55 AM View:  | Wijngaard Peter Director | Hepion Pharmaceuticals, Inc. (HEPA) | 27-Nov-23 | Purchase | 2,500 | $3.05 | $7,625.00 | 36% 7.0K to 9.5K | |
| 28-Nov-23 6:55 AM View: | Wijngaard Peter Director | Hepion Pharmaceuticals, Inc. (HEPA) | 24-Nov-23 | Purchase | 2,500 | $3.09 | $7,725.00 | 56% 4.5K to 7.0K | |
| 20-Sep-23 11:27 AM View: | Wijngaard Peter Director | Hepion Pharmaceuticals, Inc. (HEPA) | 19-Sep-23 | Purchase | 1,000 | $5.64 | $5,640.00 | 29% 3.5K to 4.5K | |
| 19-Sep-23 9:01 AM View: | Foster Robert T CEO and Director Director | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Sep-23 | Purchase | 1,600 | $5.60 | $8,960.00 | 3% 48.87K to 50.47K | |
| 20-Sep-23 11:27 AM View: | Wijngaard Peter Director | Hepion Pharmaceuticals, Inc. (HEPA) | 15-Sep-23 | Purchase | 2,000 | $5.60 | $11,201.10 | 133% 1.5K to 3.5K | |
| 18-Sep-23 8:00 AM View: | Foster Robert T CEO,CSO and Director Director | Hepion Pharmaceuticals, Inc. (HEPA) | 15-Sep-23 | Purchase | 1,600 | $5.40 | $8,640.00 | 3% 47.27K to 48.87K | |
| 18-Feb-21 4:05 PM View: | Cavan John T Chief Financial Officer | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Feb-21 | Private Purchase | 10,000 | $2.00 | $20,000.00 | 208% 4.8K to 14.8K | 9% |
| 18-Feb-21 4:05 PM View: | Foster Robert T CEO and Director Director | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Feb-21 | Private Purchase | 20,000 | $2.00 | $40,000.00 | 79% 25.26K to 45.26K | 9% |
| 18-Feb-21 4:06 PM View: | Wijngaard Peter Director | Hepion Pharmaceuticals, Inc. (HEPA) | 16-Feb-21 | Market Purchase | 10,000 | $2.20 | $22,000.00 | 50% 20.0K to 30.0K | (1%) |
| 21-Dec-20 9:17 AM View: | Wijngaard Peter Director | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Dec-20 | Market Purchase | 20,000 | $1.91 | $38,200.00 | 100% 0 to 20.0K | 13% |
| 08-Dec-20 1:56 PM View: | Foster Robert T CEO and Director Director | Hepion Pharmaceuticals, Inc. (HEPA) | 08-Dec-20 | Market Purchase | 25,000 | $1.58 | $39,417.50 | 9653% 0.26K to 25.26K | 37% |
| 02-Dec-20 6:05 PM View: | Brancaccio John P Director | Hepion Pharmaceuticals, Inc. (HEPA) | 02-Dec-20 | Market Purchase | 7,000 | $1.53 | $10,710.00 | 87500% 8 to 7.01K | 43% |
| 01-Dec-20 7:53 PM View: | Jacob Gary S Director | Hepion Pharmaceuticals, Inc. (HEPA) | 01-Dec-20 | Market Purchase | 12,000 | $1.66 | $19,920.00 | 20339% 59 to 12.06K | 29% |
| 30-Nov-20 4:53 PM View: | Cavan John T Chief Financial Officer | Hepion Pharmaceuticals, Inc. (HEPA) | 25-Nov-20 | Market Purchase | 4,500 | $1.62 | $7,290.00 | 1500% 0.3K to 4.8K | 34% |
| 05-Jan-18 1:08 PM View: | Foster Robert T Chief Scientific Officer | Hepion Pharmaceuticals, Inc. (HEPA) | 03-Jan-18 | Grant | 100,654 | -- | -- | 228% 44.08K to 144.74K | |
| 05-Jan-18 1:09 PM View: | Sapirstein James Chief Executive Officer Director | Hepion Pharmaceuticals, Inc. (HEPA) | 03-Jan-18 | Grant | 322,092 | -- | -- | 189% 170.73K to 492.82K | |
| 05-Jan-18 1:09 PM View: | Cavan John T CFO | Hepion Pharmaceuticals, Inc. (HEPA) | 03-Jan-18 | Grant | 101,221 | -- | -- | 152% 66.73K to 167.95K | |
| 07-Jul-17 5:00 PM View: | Sullivan-Bolyai John Z Chief Medical Officer | Hepion Pharmaceuticals, Inc. (HEPA) | 06-Jul-17 | Grant | 58,681 | -- | -- | 100% 0 to 58.68K | |
| 07-Jul-17 5:01 PM View: | Sapirstein James Chief Executive Officer Director | Hepion Pharmaceuticals, Inc. (HEPA) | 06-Jul-17 | Grant | 141,061 | -- | -- | 475% 29.67K to 170.73K | |
| 07-Jul-17 5:00 PM View: | Foster Robert T Chief Scientific Officer | Hepion Pharmaceuticals, Inc. (HEPA) | 06-Jul-17 | Grant | 44,082 | -- | -- | 100% 0 to 44.08K | |
| 07-Jul-17 5:01 PM View: | Cavan John T CFO | Hepion Pharmaceuticals, Inc. (HEPA) | 06-Jul-17 | Grant | 46,726 | -- | -- | 234% 20.0K to 66.73K | |
| 22-Jun-17 9:00 AM View: | Cavan John T CFO | Hepion Pharmaceuticals, Inc. (HEPA) | 20-Jun-17 | Market Purchase | 20,000 | $0.65 | $13,000.00 | 100% 0 to 20.0K | (99%) |
| 31-Oct-16 5:39 PM View: | Sapirstein James Chief Executive Officer Director | Hepion Pharmaceuticals, Inc. (HEPA) | 27-Oct-16 | Option Exercise | 16,666 | $1.50 | $24,999.00 | 128% 13.0K to 29.67K | |
| 18-Feb-16 11:10 AM View: | Sapirstein James Chief Executive Officer Director | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Feb-16 | Market Purchase | 10,000 | $1.00 | $10,000.00 | 333% 3.0K to 13.0K | (100%) |
| 01-Dec-15 4:05 PM View: | Sapirstein James Chief Executive Officer Director | Hepion Pharmaceuticals, Inc. (HEPA) | 30-Nov-15 | Market Purchase | 500 | $2.15 | $1,075.00 | 20% 2.5K to 3.0K | (100%) |
| 24-Nov-15 4:15 PM View: | Sapirstein James Chief Executive Officer Director | Hepion Pharmaceuticals, Inc. (HEPA) | 23-Nov-15 | Market Purchase | 2,500 | $1.64 | $4,100.00 | 100% 0 to 2.5K | (100%) |
| 07-Mar-14 7:29 AM View: | Brancaccio John P Director | Hepion Pharmaceuticals, Inc. (HEPA) | 04-Mar-14 | Market Purchase | 4,393 | $1.49 | $6,545.57 | 218% 2.02K to 6.41K | (100%) |
| 20-Feb-14 6:32 PM View: | Jacob Gary S CEO and President Director | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Feb-14 | Acquisition (other) | 32,935 | -- | -- | 100% 0 to 32.94K | |
| 20-Feb-14 4:58 PM View: | Synergy Pharmaceuticals, Inc. 10% Owner | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Feb-14 | Disposition (other) | 9,000,000 | -- | -- | (100%) 9.0M to 0 | |
| 20-Feb-14 6:33 PM View: | Denoyer Bernard Chief Financial Officer | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Feb-14 | Acquisition (other) | 1,030 | -- | -- | 100% 0 to 1.03K | |
| 20-Feb-14 4:58 PM View: | Brancaccio John P Director | Hepion Pharmaceuticals, Inc. (HEPA) | 18-Feb-14 | Acquisition (other) | 2,015 | -- | -- | 100% 0 to 2.02K |
